Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
CONFIGURE
Phase NA Completed
41 enrolled 6 charts
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
Phase 2 Completed
25 enrolled 11 charts
WeCanManage. An mHealth Self-management Tool
Phase NA Completed
20 enrolled
AYAConnect
Phase NA Completed
63 enrolled
ENGAGE
Phase NA Completed
292 enrolled
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Completed
62 enrolled
EARN
Phase NA Completed
33 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Phase 1 Completed
272 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
MOM
Completed
40 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
Phase NA Completed
40 enrolled
Improving Evidence-Based Care for Cancer Patients
Completed
128 enrolled
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
Phase 1/2 Completed
132 enrolled
MOVIE
Phase 1/2 Completed
126 enrolled
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
IMPACT
Phase NA Completed
19 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
CAPABLE-IT
Phase NA Completed
56 enrolled
Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer
Phase NA Completed
185 enrolled 14 charts
Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms
Phase NA Completed
50 enrolled
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Phase 1 Completed
71 enrolled
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care® Gel
Phase NA Completed
23 enrolled
REV
Phase NA Completed
41 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Phase 1 Completed
230 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
G-DEFINER
Completed
247 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
GASVERT
Phase 3 Completed
744 enrolled
DUET-2
Phase 1 Completed
150 enrolled
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
Phase 1 Completed
134 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
WiZen
Completed
670,000 enrolled
DETECT
Completed
458 enrolled
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase NA Completed
9 enrolled
Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan
Phase NA Completed
14 enrolled
Brain Stimulation For Cancer Smokers
Phase NA Completed
11 enrolled 16 charts
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety
Phase 2 Completed
1 enrolled
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Phase 1 Completed
159 enrolled